Cryptotanshinone Reverses Corticosteroid Insensitivity by Inhibition of Phosphoinositide-3-Kinase-δ in Chronic Obstructive Pulmonary Disease
Tao Xie,Rong Huang,Daishuo Deng,Peipei Tang,Yufeng Fu,Yulong Zheng,Yufeng Wan
DOI: https://doi.org/10.2147/COPD.S405757
2023-05-06
International Journal of COPD
Abstract:Tao Xie, 1 Rong Huang, 1 Daishuo Deng, 1 Peipei Tang, 2 Yufeng Fu, 2 Yulong Zheng, 1 Yufeng Wan 1 1 Department of Respiratory Diseases, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu, People's Republic of China; 2 Institute of Medicinal Biotechnology, Jiangsu College of Nursing, Huai'an, Jiangsu, People's Republic of China Correspondence: Yulong Zheng; Yufeng Wan, Department of Respiratory Diseases, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu, People's Republic of China, Tel +86 137 7670 7363 ; +86 158 0523 0282, Fax +86 517 8087 1636 ; +86 517 8087 1616, Email ; Purpose: Corticosteroid insensitivity has become a major barrier in the treatment of chronic obstructive pulmonary disease (COPD). It is known that oxidative stress reduces the expression and activity of histone deacetylase (HDAC)-2 by activating phosphoinositide-3-kinase-δ(PI3Kδ)/Akt pathway, which is a common mechanism. The aim of this study was to investigate whether cryptotanshinone (CPT) can improve corticosteroid sensitivity and to investigate the molecular mechanisms by which this occurs. Patients and Methods: Corticosteroid sensitivity in peripheral blood mononuclear cells (PBMCs) collected from COPD patients, or in human monocytic U937 monocytic cells exposed to cigarette smoke extract (CSE), was quantified as the dexamethasone concentration required to achieve 30% inhibition of tumor necrosis factor-α (TNFα)–induced interleukin 8 (IL-8) production in the presence or absence of cryptotanshinone. PI3K/Akt activity (measured as the relative ratio of phosphorylated Akt at Ser-473 to total Akt) and HDAC2 expression levels were determined by western blotting. HDAC activity was evaluated by a Fluo-Lys HDAC activity assay kit in U937 monocytic cells. Results: Both PBMCs in patients with COPD and U937 cells exposed to CSE were found to be insensitive to dexamethasone, accompanied by increased phosphorylated Akt (pAkt) and decreased HDAC2 protein expression. The pretreatment of cryptotanshinone restored their sensitivity to dexamethasone, and simultaneously downregulated the level of phosphorylated Akt and upregulated the level of HDAC2 protein. Pretreatment with cryptotanshinone or IC87114 reversed the decrease in HDAC activity in CSE-stimulated U937 cells. Conclusion: Cryptotanshinone restores corticosteroid sensitivity induced by oxidative stress via inhibition of PI3Kδ and is a potential treatment for corticosteroid-insensitive diseases such as COPD. Keywords: corticosteroid insensitivity, chronic obstructive pulmonary disease, phosphoinositide-3-kinase-δ, histone deacetylase 2, cryptotanshinone COPD is a worldwide public health problem. Nowadays, COPD has become the third leading cause of death in the world. 1 At present, there is no effective treatment to prevent the progress of COPD. Long-acting β2 agonist (LABA) and long-acting muscarinic antagonist (LAMA) are the main treatment methods for stable COPD at present, which can relieve clinical symptoms, but will not significantly affect the potential disease progression. 2 Inhalation of toxic gases and particles, including those in cigarette smoke, is a major risk factor for COPD. Chronic obstructive pulmonary disease is a chronic inflammatory disease. This inflammation is characterized by increased numbers of alveolar macrophages, neutrophils, T lymphocytes (predominantly TC1, TH1, and TH17 cells), and innate lymphoid cells recruited from the circulation. These cells secrete a variety of proinflammatory mediators, including cytokines, chemokines, growth factors, and lipid mediators. 3 In the respiratory tract, cigarette smoke and other irritants may activate alveolar macrophages and airway epithelial cells to release chemokines, and then attract circulating leukocytes to the lungs. IL-8 is one of the first chemokines to be studied in depth, and it is also a well-known neutrophil inflammatory mediator. 4 IL-8 is produced by alveolar macrophages and bronchial epithelial cells. 5 Many studies have confirmed that IL-8 plays an important role in neutrophilic inflammation in COPD airways. 6 Previous studies have confirmed TNF-α-induced IL-8 production in PBMCs is a good marker for evaluating corticosteroid sensitivity. 7 In clinical practice, inhaled corticosteroid can control asthma well, but for patients with COPD, even inhaled or oral high-dose corticosteroid have no obvious benefits. 8 Corticosteroid resistance is common in COPD patients. Corticosteroid resistance seriously hinders the effective treatment of COPD. There are many molecular mechanisms of corticosteroid insensit -Abstract Truncated-
respiratory system